Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L5 pseudogene 21 (RPL5P21) is a non-coding pseudogene found in the human genome, classified as a processed pseudogene of the RPL5 gene. Unlike its parent gene RPL5, which encodes a protein essential for ribosome structure and function, RPL5P21 does not produce a functional protein and does not participate in protein synthesis, cellular signaling, or disease mechanisms. Like many pseudogenes, RPL5P21 is a genomic sequence similar to a functional gene but rendered nonfunctional due to accumulated mutations, truncations, or regulatory changes. There are many RPL5-related pseudogenes in the human genome, and RPL5P21 is cataloged as HGNC:37029[8][7]. No evidence supports its use as a drug target, biomarker, or involvement in pathology. If you intended information on the functional ribosomal protein L5 (RPL5), please specify, as this is a well-studied protein with important roles in ribosome assembly and cell cycle regulation[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L5 pseudogene 21 (RPL5P21).